Key Takeaways
- Flat quarter, one-off driven: Revenue was flat QoQ, dragged by a single large UK healthcare program pause, GBP depreciation, and delayed deal decision-making, not broad-based demand destruction.
- MST Solutions acquisition reshapes Americas: The $80 mn purchase of a Salesforce specialist, funded by $50 mn cash and $30 mn debt, adds healthcare and government clients and a front-office capability Mastek lacked.
- Order book and pipeline provide visibility: The Middle East delivered its best order book ever, the UK DSP framework shortlisting opens a multi-billion dollar opportunity set, and delayed deals are not being cancelled.
- Margins compressed on currency and hiring: EBITDA margin fell 150 bps QoQ to 19.2% as GBP weakened and the company hired ahead of revenue; management aims to hold margins in the high teens.
- What to watch next quarter: Whether the paused UK healthcare program restarts in a smaller avatar, whether Americas organic growth materializes in H2 as promised, and the pace of MST cross-sell execution.
The UK Healthcare Pause: A Single-Account Shock
- One client, not a sector trend: A single large UK government-funded healthcare account paused a major program after a leadership change consolidated three or four departments and triggered a strategy recalibration; the pause was not driven by macro conditions.
- Ramp-up reversal: Mastek had ramped significantly on this program in Q4FY22; the sudden stop caused the Q1 revenue drop, and 60–70 people on the project were either redeployed internally or, in the case of sub-contractors, let go with no significant bench impact.
- Recovery will be smaller and phased: The program is expected to return in a different avatar, more standardized and less custom, spread into multiple phases; management expects it will take at least a quarter or two to get back to the Q4FY22 run rate in that account.
- Offsetting pipeline: Two or three other initiatives in the same account are being pursued independently, and two NHS framework deals, if converted, could offset the impact; a couple more high-value deals in the $30 mn–$50 mn range are expected in the near term.
Hiral Chandrana: "This particular situation is a little bit unique and unfortunate. We won a very large deal six months, seven months back and we were able to really ramp up... there was a leadership change and that leadership change essentially combined three or four different departments in that account and really put a pause not just on our program, but a couple of other programs as well, because they were rethinking their entire strategy for how they wanted to deliver some of that output."
Deal Delays: Pushed, Not Cancelled
- Decision-making cycles lengthened: High-probability deals expected to close in early Q1 got de-prioritized or shifted, particularly in cloud implementation; some deals were at final shortlist or contractual negotiation stage.
- Private sector caution visible across regions: Delayed decision-making cycles observed in the UK, Europe, and Americas private sector; government space normally has longer cycles by nature.
- No demand destruction: Management was explicit that most delayed deals are not lost, except for one small deal; the pipeline remains active and no cancelled demand has been seen.
- Americas execution gap: The region has been flattish for three quarters; a change in approach from project-based work to account mining and managed services is taking time to yield results, and management acknowledged being behind by a quarter.
Hiral Chandrana: "The decision-making cycle that we saw in some of our cloud implementation has taken slightly longer than we expected and that's really what we are referring to. It could be due to the macro environment, it could be due to particular customer prioritization, but the deals are not cancelled, right."
MST Solutions: The Americas Growth Bet
- Acquisition mechanics: Mastek acquired MST Solutions, a Salesforce consulting and integrator with capabilities in healthcare, state and local government, manufacturing, and financial services; the firm has 250 employees in India and 75 in the US, and was funded by $50 mn internal cash and $30 mn borrowing.
- Strategic rationale: The combination gives Mastek a seat at the table on front-office to back-office transformation engagements; MST pivoted in 2020 toward large enterprise accounts and goes deep in accounts, expanding into different divisions and Salesforce Clouds.
- Government exposure in a recession-resistant vertical: MST has high focus on state and local government in the Americas, covering fire/forestry, economic development, and land/water resources; management noted that state and local government spend continues to be very high even in a recession-type environment.
- Cross-sell starting immediately: 25 accounts have been identified for cross-sell between Mastek and MST, split across UK and Americas; one deal is already being worked on together, and account team meetings were scheduled for August.
- Integration timeline: Most integration expected to be complete before the end of this fiscal year; MST leaders will all continue, with a retention program built into the deal value.
- Revenue ambition: Management sees the Salesforce ecosystem business reaching $150 mn to $200 mn over time, with organic growth 10–15% ahead of the industry growth rate, amplified by integrated deals and offerings.
Hiral Chandrana: "The spend of this state and local government still continues to be very high. And even with a recession type of environment, we like the healthcare and state and local government focus."
UK Public Sector: Stable and Growing
- Core business insulated from politics: Management does not see the UK political scenario impacting the core secure government services business; top accounts have longer-term predictable engagements with two to three years of visibility.
- Ex-healthcare growth: If currency impact is removed, the UK public sector business actually grew in Q1, reflected in both the government/education industry slice and the digital engineering slice.
- DSP framework win: Mastek was shortlisted among 20 suppliers out of approximately 50 for both lots of the Digital Specialists and Programs framework, giving access to a multi-billion dollar opportunity set across central government, health teams, and defense teams over the next few years.
- New government as opportunity: A potential reduction in civil servants presents an opportunity for Mastek, and a new government could bring new initiatives or rethinking of existing ones.
- Deal tenure shifting: Some engagements have been converted into one-to-two-year engagements for more predictability.
Hiral Chandrana: "As of right now, we don't see the political scenario impacting us in the core secure government services business that we currently have."
Margins, Cash, and People
- EBITDA margin walk: Fell to 19.2% from 20.7% QoQ, driven by GBP depreciation against the INR, increased salary levels from supply-side challenges as the company ramps for key wins, and utilization impact from hiring ahead of revenue.
- North America margin correction: A significant EBITDA margin drop in North America was driven by a combination of a one-timer, expected to normalize in Q2, and continued investments.
- Cash and DSO: Gross cash declined to Rs.665 crores from Rs.794 crores QoQ; net cash declined to Rs.490 crores from Rs.600 crores; DSO increased due to seasonality at a couple of customers and contract signature timing, believed to be one-time and expected to settle in the next 90 days.
- Hiring ahead of revenue: Employee additions are aligned to a healthy pipeline and strong order backlog; hiring is planned for the next nine months of revenue forecast, and some hires will take time to become fully productive.
- Attrition trending down: In contrast to most peers, attrition is declining, attributed to employee engagement measures started in late 2021: cutting-edge tech work, career opportunities, direct leadership engagement, and an 'Aspire' program for top talent.
- Wage revision: The Q2FY23 cycle is still under discussion; more information expected in coming months.
- Margin ambition: Management endeavors to maintain high teens EBITDA; depending on currency, closer to 20%.
Strategic Shifts: Annuity, Account Focus, and M&A Roadmap
- Annuity business building: The share of fixed-price and annuity business has moved to the 30–35% range over the last six to nine months, driven by converting implementations into managed services, rebranded as cloud enhancement services because the on-premise managed services model does not hold in the new digital/SaaS landscape.
- Ambition to reach 50%: Management wants to move the annuity mix closer to 50% over time.
- Client rationalization: Mastek consciously reduced the number of accounts by almost 50 while delivering the same revenue, as part of a focus on account mining and higher quality revenue.
- M&A roadmap: Three to five acquisitions are planned over three to four years; two other pillars beyond Salesforce have been identified: cloud platforms in the Azure/AWS space, and data/automation; more acquisitions are expected over the next couple of years.
- New platform expansion: Beyond Microsoft, Salesforce, and Oracle, Mastek has started looking at UiPath, AWS, and Snowflake.
- Discretionary vs. non-discretionary: Management declined to quantify a split, calling it difficult and dependent on customer priorities; 95% of work is in SaaS/digital/cloud migration space and tied to business process KPIs, making the classification tricky.
Arun Agarwal: "Discretionary spend has to be seen from the eyes of the customers... most of this project has a significant ROI for the customer. But again when you get into discretionary and non-discretionary, depends on the priority of the customer, right."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| UK healthcare account recovery | Paused program returns in smaller, phased, standardized avatar; two to three other initiatives in same account pursued independently | At least one to two quarters to return to Q4FY22 run rate in that particular account |
| Americas organic growth | Expect a decent jump in both order book and revenue growth | H2FY23 (Q3 and Q4) |
| North America EBITDA margin | One-timer that drove significant margin correction expected to normalize | Q2FY23 |
| DSO normalization | One-time increase expected to settle back to quarterly run rate | Next 90 days |
| MST integration | Most integration expected to be complete | Before end of FY23 |
| Industry-beating growth | Expect to start beating industry growth QoQ after recovery period | Post three to four quarters |
| Tax rate | 24% to 25% on a normalized basis | FY23 |
| EBITDA margin | Endeavor to maintain high teens; closer to 20% depending on currency | Ongoing |
| NHS framework deals | Two deals, if converted, could offset healthcare pause impact; two more high-value deals ($30 mn–$50 mn) expected in the pipeline | Near term (three to six months) |
| M&A roadmap | Three to five acquisitions across cloud platforms and data/automation pillars | Over three to four years |
Key Metrics
| Metric | Q1 FY23 |
|---|---|
| Revenue | ₹570 cr, +13.4% YoY constant currency, flat QoQ |
| Operating EBITDA margin | 19.2%, vs 20.7% in Q4 FY22; impacted by GBP depreciation and salary increases |
| PAT | ₹84.4 cr (14.2% of income), vs ₹88.2 cr (14.7% of income) in Q4 FY22 |
| Revenue from UK | 65%-plus of total revenue |
| Constant currency revenue growth | 13.4% YoY |
| Backlog growth | Over 30% YoY |
| Gross cash | ₹665 cr, vs ₹794 cr in Q4 FY22 |
| Cash net of debt | ₹490 cr, vs ₹600 cr in Q4 FY22 |
| Headcount | 5,553, net addition of 576 resources during the quarter |
| New clients added | 33 during the quarter |
| Fortune 1,000 customer base | 21, vs 19 in Q4 FY22 |
| Annuity business contribution | 30% to 35% of revenue; ambition to move closer to 50% |
| Attrition | Trending downwards |
| DSO | Increased due to seasonality in a couple of customers and certain contract signatures; expected to normalize in Q2 FY23 |
| Tax rate expectation for FY23 | 24% to 25% on a normalized basis |